Trump’s COVID-19 Experience Doesn’t Prove Anything. According to The Verge, President Trump says he’s recovered from covid-19. Outside doctors said it’s too soon for him to return to public events, he’s coughing on Fox News, and he’s taking a potent steroid that can mask symptoms, but Trump says he’s not sick anymore. And he’s crediting that recovery to an experimental drug made by the company Regeneron, which he said on Wednesday was a cure.
He said in a video recorded at the white house “ They gave me Regeneron, and it was, like, unbelievable. I felt good immediately.”
Further, there’s no evidence that the Regeneron drug had anything to do with how good Trump did or did not feel. There’s hardly any info that the drug, which is a cocktail of artificial antibodies against the covid-19, works at all. We only have few bits of information on a small group of patients that were published in a press release.
Donald Trump was also given two other drugs, the antiviral redeliver and the steroid dexamethasone. So there’s no reason to believe the Regeneron drug- which is actually named REGN-COV2; Regeneron is the name of the company that produces it- was the thing responsible for how he said he felt.
Trump’s COVID-19 Experience Doesn’t Prove Anything
Antibody treatments could be a good way to treat covid-19. This strategy is similar to convalescent plasma, which contains coronavirus antibodies generated by recovered patients. So, instead of an unpredictable mixture of antibodies that seem to be particularly good at blocking the virus.
But neither drug has been tested thoroughly enough to say if it helps, hurts, or does nothing. President Trump’s wild claims about Regeneron’s candidate could make finding answers harder. That’s what happens the last time he talked up a treatment strategy-remember hydroxychloroquine? Donald Trump’s constant promotion of the anti-malarial drug, and the controversy around it, made people reluctant to enroll in clinical trials that were designed to figure out if actually worked.
Moreover, Trump also pressured federal agencies to quickly push out hydroxychloroquine. Experts worry’s that something similar could happen with Regeneron antibody therapy. President Trump is already pushing the food and drug administration to authorize it quickly. The circumstances of his treatment also could skew the clinical trial process: he got the drug under compassionate use, which makes untested and experimental products available to people who are seriously ill. Thus, seeing it as a makes it seem as if we know more about it than we actually do, while simultaneously leaving the impression that VIPs like the president can skip the line, while the rest of us run the risk of getting a placebo in a clinical trial.
There’s no confirmation yet of someone who gets the drug being better off than someone who gets a placebo. Hopefully, the drug works but anyone who claims to have answered right now is just making things up.